目标很大，细节不知道。
============================
Chinese Genomicists Target Cancer

The $10 million Cancer Genome project, announced last week, marks China's first large-scale research program targeting a specific clinical disease. The program focuses on variations at the structural genomic and sequence levels, epigenomics, and transcriptomics, says Yang Huanming, director of the Beijing Genomics Institute. The program will carry out research into cancers that are prevalent in China, which could include lung, liver, stomach, and esophageal cancers. U.S. National Cancer Institute official Daniela Gerhard calls the project "a good idea," noting China's unique tumor samples. Although China is a partner in the international Human Genome and HapMap projects, Gerhard says the United States will wait for more details before considering partnering on the latest effort.

http://www.sciencemag.org/content/vol314/issue5799/s-scope.dtl?rss=1